tiprankstipranks
Trending News
More News >
Nuo Therapeutics (AURX)
OTHER OTC:AURX
US Market

Nuo Therapeutics (AURX) Income Statement

Compare
11 Followers

Nuo Therapeutics Income Statement

Last quarter (Q3 2025), Nuo Therapeutics's total revenue was $1.03M, an increase of 178.23% from the same quarter last year. In Q3, Nuo Therapeutics's net income was $-537.92K. See Nuo Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Mar 22Dec 20
Total Revenue
$ 1.37M$ 608.52K$ 112.25K$ 0.00$ 0.00
Gross Profit
$ 1.06M$ 482.43K$ 93.04K$ 0.00$ 0.00
Operating Expenses
$ 3.52M$ 3.65M$ 3.41M$ 90.67K$ 378.06K
Depreciation and Amortization
$ 96.27K$ 105.26K$ 74.08K$ 90.67K$ 89.86K
EBITDA
$ -2.36M$ -3.06M$ -3.10M$ 0.00$ -288.20K
Operating Income
$ -2.46M$ -3.17M$ -3.32M$ -90.67K$ -378.06K
Other Income/Expenses
$ 134.13K$ -3.16K$ 148.86K$ 0.00$ 287.19K
Pretax Income
$ -2.32M$ -3.17M$ -3.17M$ -90.67K$ -90.87K
Net Income
$ -2.32M$ -3.17M$ -3.03M$ -90.67K$ -139.26K
Per Share Metrics
Basic EPS
$ -0.05$ -0.08$ -0.08$ 0.00$ -0.01
Diluted EPS
$ -0.05$ -0.08$ -0.08$ 0.00$ -0.01
Weighted Average Shares Outstanding
45.42M 42.08M 40.00M 30.30M 25.69M
Weighted Average Shares Outstanding (Diluted)
45.42M 42.08M 40.00M 30.30M 27.31M
Currency in USD

Nuo Therapeutics Earnings and Revenue History